Press releases

Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation

| Non-regulatory
Read more

First publication from South Africa and first stem cell transplantation performed in Mexico

| Non-regulatory
Read more

Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania

| Non-regulatory
Read more

Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.

| Regulatory
Read more

Glycorex Transplantation AB (publ): Interim Report January – September 2023

| Regulatory
Read more

Glycorex Transplantation AB (publ): Interim Report January – June 2023

| Regulatory
Read more

Glycorex appoints Lars Juliusson as Business Development Manager Transfusion

| Non-regulatory
Read more

Glycorex Transplantation AB (publ): Interim Report January – March 2023

| Regulatory
Read more

Annual Report 2022 Glycorex Transplantation AB (publ)

| Regulatory
Read more

Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood

| Non-regulatory
Read more

Year-end Report 2022

| Regulatory
Read more

The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa

| Non-regulatory
Read more

Subscribe to our releases

Choose categories

Contact information

The subscription service is provided by Cision.se and your information will be stored on their servers. The information will only be used to send you notifications when new releases are published. No personal information will be shared with any outside parties. Read more about our Privacy Policy.

News

Johan Lavén, CEO presenting Glycorex Transplantation on Aktiedagen (Aktiespararna) September 19 2023.

The presentation on Youtube >>

Geert Nygaard, CEO presenting Glycorex Transplantation on Aktiedagen (Aktiespararna) januari 31 2022.

The presentation on Youtube >>

Pontus Nobréus, CEO presenting Glycorex Transplantation on Redeye Growth Day june 2.
Presentationen >>

Download the presentationen >>

 

Pontus Nobréus, CEO presenting Glycorex Transplantation  BioStock Life Science Spring Summit on May 26
https://youtu.be/5fpTsNENiO8

Download the presentation >>

Glycorex Transplantation is a proud collaborator with The Hospital Clínic de Barcelona in Spain. It recently became the first hospital in Spain to carry out more than 1,000 living donor kidney transplants. To celebrate this milestone, a campaign called “A thousand transplants, a thousand stories” was launched to increase public awareness and encourage living donor kidney donations. https://www.clinicbarcelona.org/en/news/the-hospital-clinic-the-first-hospital-in-spain-to-carry-out-1-000-living-donor-kidney-transplants

REDEYE GROWTH DAY
Pontus Nobréus, CEO of Glycorex Transplantation will present at the Redeye Growth Day on June 2, 2021 at 08:50 CET.
Link to live streaming: https://www.redeye.se/events/808637/redeye-growth-day-2021

Glycorex Transplantation participates in the BioStock Life Science Spring Summit 2021. CEO Pontus Nobréus will present the company at the BioStock Life Science Spring Summit on May 26-27. For more information please visit: www.summit.biostock.se

Tomorrow, april 29th, Dr Guirado from Spain will discuss ABO incompatible kidney transplantations in a live Zoom seminar, arranged by our distributor in Mexcio, Ryse Médica and Sociedad Mexicana De Transplantes.

https://us02web.zoom.us/j/85789158554

Scheelevägen 27 | SE-223 63 Lund, Sweden

Phone: +46 46 286 52 30  | Fax: +46 46-286 52 39
E-mail: info@glycorex.com

Org.nr: 556519-7372

© 2022 Glycorex Transplantation AB. Registered office in Lund, Sweden . All rights reserved.